Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

665 ARTÍCULOS , VIENDO DEL 631 AL 645

Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy

Voicu V, Brehar FM, Toader C, Covache-Busuioc RA, Corlatescu AD, Bordeianu A, Costin HP, Bratu BG, Glavan LA, Ciurea AV.

Biomolecules. 2023 Sep 14;13(9):1388. doi: 10.3390/biom13091388.

Molecular mechanisms of neuroprotective offerings by rosmarinic acid against neurodegenerative and other CNS pathologies

Ravaria P, Saxena P, Laksmi Bs S, Ranjan V, Abidi SWF, Saha P, Ramamoorthy S, Ahmad F, Rana SS.

Phytother Res. 2023 May;37(5):2119-2143. doi: 10.1002/ptr.7825. Epub 2023 Apr 4.

The potential of CYP46A1 as a novel therapeutic target for neurological disorders: An updated review of mechanisms

Alavi MS, Karimi G, Ghanimi HA, Roohbakhsh A.

Eur J Pharmacol. 2023 Jun 15;949:175726. doi: 10.1016/j.ejphar.2023.175726. Epub 2023 Apr 14.

Therapeutic implications of phosphorylation- and dephosphorylation-dependent factors of cAMP-response element-binding protein (CREB) in neurodegeneration

Khakha N, Khan H, Kaur A, Singh TG.

Pharmacol Rep. 2023 Oct;75(5):1152-1165. doi: 10.1007/s43440-023-00526-9. Epub 2023 Sep 9.

Targeting mitophagy for neurological disorders treatment: advances in drugs and non-drug approaches

Yang X, Zhang Y, Luo JX, Zhu T, Ran Z, Mu BR, Lu MH.

Naunyn Schmiedebergs Arch Pharmacol. 2023 Dec;396(12):3503-3528. doi: 10.1007/s00210-023-02636-w. Epub 2023 Aug 3.

Kaempferol, a potential neuroprotective agent in neurodegenerative diseases: From chemistry to medicine

Jin S, Zhang L, Wang L.

Biomed Pharmacother. 2023 Sep;165:115215. doi: 10.1016/j.biopha.2023.115215. Epub 2023 Jul 24.

Challenges and Discoveries in Polypharmacology of Neurodegenerative Diseases

Lustoza Rodrigues TCM, de Sousa NF, Dos Santos AMF, Aires Guimarães RD, Scotti MT, Scotti L.

Curr Top Med Chem. 2023;23(5):349-370. doi: 10.2174/1568026623666230126112628.

Mitochondrial Medicine: A Promising Therapeutic Option Against Various Neurodegenerative Disorders

Almikhlafi MA, Karami MM, Jana A, Alqurashi TM, Majrashi M, Alghamdi BS, Ashraf GM.

Curr Neuropharmacol. 2023;21(5):1165-1183. doi: 10.2174/1570159X20666220830112408.

Towards Understanding Neurodegenerative Diseases: Insights from Caenorhabditis elegans

Wu Y, Chen Y, Yu X, Zhang M, Li Z.

Int J Mol Sci. 2023 Dec 28;25(1):443. doi: 10.3390/ijms25010443.

Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders

Gupta R, Advani D, Yadav D, Ambasta RK, Kumar P.

Mol Neurobiol. 2023 Nov;60(11):6476-6529. doi: 10.1007/s12035-023-03502-9. Epub 2023 Jul 17.

Memantine administration prevented chorea movement in Huntington's disease: a case report

Saigoh K, Hirano M, Mitsui Y, Oda I, Ikegawa A, Samukawa M, Yoshikawa K, Yamagishi Y, Kusunoki S, Nagai Y.

J Med Case Rep. 2023 Oct 16;17(1):431. doi: 10.1186/s13256-023-04161-z.

Cyclitols: From Basic Understanding to Their Association with Neurodegeneration

Derkaczew M, Martyniuk P, Osowski A, Wojtkiewicz J.

Nutrients. 2023 Apr 23;15(9):2029. doi: 10.3390/nu15092029.

Antiplatelet drugs: Potential therapeutic options for the management of neurodegenerative diseases

Beura SK, Dhapola R, Panigrahi AR, Yadav P, Kumar R, Reddy DH, Singh SK.

Med Res Rev. 2023 Nov;43(6):1835-1877. doi: 10.1002/med.21965. Epub 2023 May 3.

Caenorhabditis elegans: A transgenic model for studying age-associated neurodegenerative diseases

Rani N, Alam MM, Jamal A, Bin Ghaffar U, Parvez S.

Ageing Res Rev. 2023 Nov;91:102036. doi: 10.1016/j.arr.2023.102036. Epub 2023 Aug 19.

Research on ferroptosis as a therapeutic target for the treatment of neurodegenerative diseases

Wang Y, Lv MN, Zhao WJ.

Ageing Res Rev. 2023 Nov;91:102035. doi: 10.1016/j.arr.2023.102035. Epub 2023 Aug 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias